Cefuroxime 750mg Powder for Injection

*
Pharmacy Only: Prescription
  • Company:

    Flynn Pharma Ltd
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may be renewed (B)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 14 April 2023

File name

SmPC 750mg 2023 04 03.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Update in line with PRAC

Updated on 14 April 2023

File name

PlTI Cefuroxime IE (Verona) 19.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Free text change information supplied by the pharmaceutical company

Update in line with PRAC

Updated on 24 June 2022

File name

SmPC 750mg 2022 06 23.pdf

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

MAH address change

Updated on 24 June 2022

File name

PIL mockup 2022 06 23.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder

Free text change information supplied by the pharmaceutical company

MAH address change

Updated on 19 January 2021

File name

Cefuroxime 750mg and 1.5g PIL 2018.pdf

Reasons for updating

  • New PIL for new product

Updated on 06 August 2018

File name

131-spc-injection750mg-clean.pdf

Reasons for updating

  • Change to section 3 - Pharmaceutical form

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

align with Zinacef including EUCAST updates; update of reconstitution instructions including description of solution; upate of sodium warning in line with updates to Excipients Guideline

Updated on 28 February 2018

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 28 February 2018

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 7 - Marketing authorisation holder

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

to add a warning about the use intracameral and update the MA holder address

Updated on 28 February 2018

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 7 - Marketing authorisation holder

Free text change information supplied by the pharmaceutical company

to add a warning about the use intracameral and update the MA holder address

Updated on 26 February 2016

Reasons for updating

  • Improved electronic presentation

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

QRD update

Updated on 26 February 2016

Reasons for updating

  • Improved electronic presentation

Free text change information supplied by the pharmaceutical company

QRD update

Updated on 13 July 2012

Reasons for updating

  • New SPC for medicines.ie

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

None provided

Updated on 13 July 2012

Reasons for updating

  • New SPC for medicines.ie

Free text change information supplied by the pharmaceutical company

None provided